The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NeoGenomics Inc. COM NEW 64049M209 106,259 2,203,165 SH   SOLE   2,203,165 0 0
Horizon Therapeutics Public Limited Company SHS G46188101 50,325 546,775 SH   SOLE   546,775 0 0
Vericel Corporation COM 92346J108 31,890 574,080 SH   SOLE   574,080 0 0
Five9, Inc. COM 338307101 10,400 66,525 SH   SOLE   66,525 0 0
ISHARES TR CORE 1 5 YR USD 46432F859 105 2,050 SH   SOLE   2,050 0 0
ISHARES TR CORE S&P500 ETF 464287200 116 292 SH   SOLE   292 0 0
ISHARES TR CORE MSCI EAFE 46432F842 13,122 182,128 SH   SOLE   182,128 0 0
ISHARES TR CORE INTL AGGR 46435G672 43 783 SH   SOLE   783 0 0
ISHARES TR CR 5 10 YR ETF 46435G417 39 764 SH   SOLE   764 0 0
ISHARES TR CORE S&P MCP ETF 464287507 38 147 SH   SOLE   147 0 0
ISHARES TR CORE MSCI EMKT 46434G103 12,664 196,766 SH   SOLE   196,766 0 0
ISHARES TR CORE S&P SCP ETF 464287804 22 207 SH   SOLE   207 0 0